Hikma Pharmaceuticals eyes $1 billion purchase of CorePharma
I realise most of the dealmaking community is currently focused on the risk that some large pharmaceutical deals may collapse. But I have stumbled across a potential pharmaceutical deal that is unlikely to be affected by the US government's attempt to clamp down on corporate "tax inversions"...
Register
Register for free to see rest of this article and all public articles from Betaville
Login / RegisterDate: Wednesday, 24 September 2014, 2:05 am